Prinzipien der antithrombotischen Therapie bei arteriellen Erkrankungen-Reference-Cited by-同舟云学术

Prinzipien der antithrombotischen Therapie bei arteriellen Erkrankungen

Published:2021 Issue: Volume: Page:1-6
ISSN:2625-3461
Container-title:Klinische Angiologie
language:
Short-container-title:

Author:

Espinola-Klein Christine

Publisher

Springer Berlin Heidelberg

Link

https://link.springer.com/content/pdf/10.1007/978-3-662-61379-5_17-1

Reference23 articles.

1. Aboyans V, Ricco JB, Bartelink MEL et al (2017) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. https://doi.org/10.1093/eurheartj/ehx095

2. Aboyans V, Bauersachs R, Mazzolai L et al (2021) Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J 42(39):4013–4024 (14 October 2021). https://doi.org/10.1093/eurheartj/ehab390

3. Anand SS, Bosch J, Eikelboom JW et al (2017) Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. pii: S0140-6736(17)32409-1

4. Belch J, MacCuish A, Campbell I et al (2008) The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:a1840

5. Belch JJ, Dormandy J (2010) CASPAR Writing Committee Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 52:825–833